CINECA IRIS Institutional Research Information System

FUNEL, NICCOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.446
EU - Europa 4.414
AS - Asia 3.641
SA - Sud America 482
AF - Africa 224
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 6
Totale 21.223
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.631
CA - Canada 4.761
IT - Italia 1.285
SG - Singapore 1.153
CN - Cina 1.095
PL - Polonia 1.043
HK - Hong Kong 643
SE - Svezia 554
BR - Brasile 400
DE - Germania 331
BG - Bulgaria 294
GB - Regno Unito 213
VN - Vietnam 202
IN - India 142
TR - Turchia 135
RU - Federazione Russa 131
FR - Francia 93
UA - Ucraina 88
AT - Austria 87
FI - Finlandia 87
CI - Costa d'Avorio 76
JP - Giappone 60
NL - Olanda 50
SN - Senegal 42
CH - Svizzera 41
KR - Corea 41
NG - Nigeria 33
BE - Belgio 29
AR - Argentina 28
MX - Messico 25
BD - Bangladesh 22
IE - Irlanda 19
ZA - Sudafrica 19
EC - Ecuador 18
PK - Pakistan 18
TW - Taiwan 18
ES - Italia 17
MA - Marocco 16
IQ - Iraq 15
EG - Egitto 14
ID - Indonesia 12
CZ - Repubblica Ceca 11
UZ - Uzbekistan 11
TN - Tunisia 10
VE - Venezuela 10
AU - Australia 9
SA - Arabia Saudita 9
PH - Filippine 7
AE - Emirati Arabi Uniti 6
BJ - Benin 6
CO - Colombia 6
JO - Giordania 6
LT - Lituania 6
PY - Paraguay 6
EU - Europa 5
IL - Israele 5
MY - Malesia 5
NP - Nepal 5
PA - Panama 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
BO - Bolivia 4
CL - Cile 4
CR - Costa Rica 4
IR - Iran 4
JM - Giamaica 4
KZ - Kazakistan 4
LU - Lussemburgo 4
PT - Portogallo 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
AL - Albania 3
AZ - Azerbaigian 3
GR - Grecia 3
HU - Ungheria 3
MO - Macao, regione amministrativa speciale della Cina 3
NO - Norvegia 3
RO - Romania 3
BB - Barbados 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
KE - Kenya 2
KG - Kirghizistan 2
KY - Cayman, isole 2
LB - Libano 2
OM - Oman 2
SV - El Salvador 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BM - Bermuda 1
BY - Bielorussia 1
CG - Congo 1
CU - Cuba 1
DK - Danimarca 1
DZ - Algeria 1
GE - Georgia 1
GM - Gambi 1
GY - Guiana 1
Totale 21.214
Salva come PNG Salva come JPEG
Città #
Montreal 4.590
Woodbridge 837
Ashburn 822
Hong Kong 640
Singapore 584
Fairfield 538
Chandler 513
Santa Clara 511
Ann Arbor 487
Dallas 431
Houston 391
Milan 330
Sofia 293
Shanghai 266
Beijing 214
Wilmington 210
Seattle 201
Cambridge 193
New York 192
Serra 180
Boardman 151
Princeton 144
Ottawa 139
Jacksonville 119
Lawrence 110
Los Angeles 102
Dearborn 100
Medford 85
Pisa 85
Florence 83
Vienna 78
London 77
Abidjan 76
Izmir 75
Nanjing 73
Boulder 67
Rome 55
Des Moines 54
Munich 51
Frankfurt am Main 50
Redwood City 47
Dakar 42
Bern 40
Buffalo 40
Istanbul 39
San Diego 38
Tokyo 37
Hefei 36
Ho Chi Minh City 36
Dong Ket 33
Lagos 33
Nanchang 33
Redondo Beach 33
Hyderabad 32
São Paulo 31
Kunming 29
Seoul 28
Washington 28
Nuremberg 27
Shenyang 27
Chicago 26
Bremen 25
Düsseldorf 25
Ogden 25
Brussels 24
Columbus 22
Fuzhou 22
Livorno 22
Guangzhou 21
Grafing 20
Jüchen 20
Hanoi 19
Kent 19
The Dalles 19
Warsaw 18
Council Bluffs 17
Lucca 16
Changsha 14
Manchester 14
Norwalk 14
Hangzhou 13
Hebei 13
Orem 13
Paris 13
Jiaxing 12
San Jose 12
Turku 12
Brooklyn 11
Falls Church 11
Jakarta 11
Marseille 11
Poplar 11
Rio de Janeiro 11
San Francisco 11
Stockholm 11
Tianjin 11
Denver 10
Taipei 10
Tashkent 10
Toronto 10
Totale 15.515
Salva come PNG Salva come JPEG
Nome #
CORRELATION OF GENE EXPRESSION PROFILES WITH CLINICAL RESPONSE TO GEMCITABINE IN PANCREATIC CANCER 3.291
PANCREATIC METASTASES FROM RENAL CARCINOMA 2.554
Zebrafish embryos as avatar of patients with pancreatic cancer: preliminary results of validation a new model toward personalized medicine 269
GLUT1 and LOX inhibitors as perspective anticancer agents tackling glucose avidity and ECM remodeling in tumors 245
Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine 216
Sonde diagnostiche per evidenziare all’infrarosso cellule e tessuti affetti da condizioni patologiche o metaboliche 213
Anti-diabetic properties of a non-conventional radical scavenger, as compared to pioglitazone and exendin-4, in streptozotocin-nicotinamide diabetic mice. 202
Interfacing polymeric scaffolds with primary pancreatic ductal adenocarcinoma cells to develop 3D cancer models 201
Magnetic carbon nanotubes: a new tool for shepherding mesenchymal stem cells by magnetic fields 197
Abdominal ultrasound scan for the follow-up of pancreatic cystic lesions: could it play a role as a safe and cost-saving alternative to the routine MRI? 191
Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET 190
Discovery of N-Hydroxyindole-Based Inhibitors of Human Lactate Dehydrogenase Isoform a (LDH-A) as Starvation Agents against Cancer Cells 187
Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer 182
Diagnostic probes to detect cells and tissues afflicted with a pathological or metabolic condition by means of infrared spectroscopy 181
Contrast enhancement pattern on multidetector CT predicts malignancy in pancreatic endocrine tumours 177
The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancer 176
Mesenchymal stem cells and magnetic nanoparticles: in vitro studies and in vivo protocol validation for cellular homing into a target organ by magnetic fields 172
Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET 172
Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia 171
Cellular Transfection Evidence in Pancreatic Tumor Primary Cell Cultures Through Electroporation of Green Fluorescent Protein (GFP) 168
Robotic-assisted versus open left pancreatectomy for cystic tumours: A single-centre experience 162
Preclinical emergence of novel lactate dehydrogenase inhibitors as potent antitumor agents in hypoxic models of pancreatic cancer: molecular mechanisms underlying their synergistic interaction with gemcitabine 160
RNA-SCOPE TECHNOLOGY AND IMMUNOHISTOCHEMISTRY REVEAL LOW EXPRESSION OF MUC5AC IN METASTATIC PANCREATIC PATIENTS: EPIGENETIC PITFALLS OR A BETTER DISEASE STATUS? 160
Epigenetic expression of MUC5AC in metastatic pancreatic patients using RNA-scope technology and immunohistochemistry 160
Liver fat accumulation and isolated islets function in non-diabetic and type 2 diabetic subjects 159
Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia. 159
EUS-FNA wet technique for the pre-operative diagnosis of 31 solid pancreatic tumors: Pisa experience 158
Homozygosis Mutation in K-ras Oncogene in Primary Cell Culture from Pancreatic Ductal Adenocarcinoma. Characteristic of the Tumor or Adaptation in Vitro? 157
Use of zebrafish embryos as avatar of patients with pancreatic cancer: A new xenotransplantation model towards personalized medicine 157
Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma 156
The MEK1/2 inhibitor pimasertib enhances gemcitabine efficacy-letter 156
SINGLE INSTITUTION EXPERIENCE WITH PANCREATECTOMIES ASSOCIATED TO VASCULAR RESECTION 155
Role of CYB5A in pancreatic cancer prognosis and autophagy modulation. 154
Multidetector CT in the evaluation of retroperitoneal fat tissue infiltration in ductal adenocarcinoma of the pancreatic head: correlation with histopathological findings. 154
Ampullary adenocarcinomas: The immunohistochemical score of CDX2, CK7 and CK 20 identify pathological subtypes and their prognosis 151
Genes involved in gemcitabine activity: pancreas cancer vs primary cell cultures 150
FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer 150
Loss of 18q22.3 involving the carboxypeptidase of glutamate-like gene is associated with poor prognosis in resected pancreatic cancer 150
3D IN VITRO MODEL OF PANCREATIC DUCTAL ADENOCARCINOMA: NEW STRATEGY TO STUDY PANCREATIC DUCTAL ADENOCARCINOMA 150
CHARACTERIZATION OF HUMAN ISLETS IN POLYELECTROLYTE MULTILAYER CAPSULES 149
Persistent correction of hyperglycemia in streptozotocin-nicotinamide-induced diabetic mice by a non-conventional radical scavenger 149
The biology of regulatory pathways of miRNAs, mRNAs and proteins unravels a specific -omics network in tumor-educated platelets from pancreatic cancer patients 148
MET as a potential target for the treatment of upper gastrointestinal cancers: characterization of novel c-Met inhibitors from bench to bedside. 147
Abstract 3082: Targeting hypoxic pancreatic cancer cells with glucose conjugated lactate dehydrogenase inhibitor NHI-Glc-2 147
A PERSONAL INVAGINATION PANCREATICOJEJUNOSTOMY TECHNIQUE AFTER PANCREATICODUODENECTOMY: DESCRIPTION, TECHNICAL DETAILS AND RESULTS 146
THE IMMUNOHISTOCHEMICAL SCORE OF CDX2, CK7 AND CK 20 CAN IDENTIFY PATHOLOGICAL SUBTYPES OF AMPULLARY ADENOCARCINOMAS AND THEIR PROGNOSIS 146
The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies 144
DUODENO-PANCREATECTOMY WITHOUT VASCULAR RESECTION FOR ISHIKAWA TYPE B ADENOCARCINOMA: UNDERTREATMENT OR NOT? 143
Lights and shadows of molecular pathology and immunotherapy in adjuvant setting of patients with pancreatic ductal adenocarcinoma: Tumor volume and microsatellite instability inversely affect early progression free survival 143
Crizotinib inhibits metabolic inactivation of gemcitabine in c-Met-driven pancreatic carcinoma. 142
Adjuvant chemotherapy seems beneficial for invasive intraductal papillary mucinous neoplasms. 142
Pancreatoduodenectomy without Vascular Resection in Patients with Primary Resectable Adenocarcinoma and Unilateral Venous Contact: A Matched Case Study 142
PROGNOSTIC IMPACT OF CONSERVATIVE SURGERY FOR PANCREATIC IPMNS 142
Study of apoptosis induction and deoxycytidine kinase/cytidine deaminase modulation in the synergistic interaction of a novel ceramide analog and gemcitabine in pancreatic cancer cells 141
Surgical Treatment of Neuroendocrine Tumors of the Pancreas: Results and Prognostic Factors 140
Evaluation of vascular infiltration in resected patients for pancreatic cancer: comparison among multidetector CT, intraoperative findings and histopathology 140
Tuning scaffold pore features to accomplish biomimicry in liver and pancreas 3D tumor models: a study on cancer cell aggregation, migration and morphotype transition 138
THE ROUTINE USE OF SOMATOSTATIN ANALOGUES AFTER PANCREATODUODENECTOMY: ITS CLINICAL IMPACT BASED ON A CASE-MATCHED COMPARISON ACCORDING TO FISTULA RISK SCORE, ASA AND SURGICAL TECHNIQUE 138
CONSERVATIVE SURGERY FOR PANCREATIC IPMNS: PROGNOSTIC IMPACT ON TUMOR PROGRESSION AND ON QUALITY OF LIFE 137
SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival 136
Detailing the ultrastructure’s increase of prion protein in pancreatic adenocarcinoma 136
THE IMMUNOHISTOCHEMICAL SCORE OF CDX2, CK7 AND CK 20 IDENTIFY PATHOLOGICAL SUBTYPES AND THEIR PROGNOSIS IN AMPULLARY ADENOCARCINOMAS PATIENTS 135
EUS-FNA WET-TECHNIQUE IN 31 SOLID PANCREATIC LESIONS: PISA EXPERIENCE 133
Synergistic Interaction of Novel Lactate Dehydrogenase Inhibitors with Gemcitabine in Hypoxic Models of Pancreatic Cancer 132
New platforms for PDAC preclinical studies: 3d tissue engineered models based on primary cancer cells and synthetic scaffolds 132
ISHIKAWA TYPE B ADENOCARCINOMA OF THE PANCREATIC HEAD: DUODENO-PANCREATECTOMY WITHOUT VASCULAR RESECTION AN ONCOLOGICALLY ACCEPTABLE OPTION? 132
Impact of hypoxia on chemoresistance of mesothelioma mediated by the proton-coupled folate transporter, and preclinical activity of new anti-LDH-A compounds 131
. THE ROLE OF ABDOMINAL ULTRASOUND SCAN FOR THE FOLLOW-UP OF PANCREATIC CYSTIC LESIONS: A COST- SAVING AND SAFE ALTERNATIVE TO THE ROUTINE USE OF MRI? 130
HEPATOSTEATOSIS AND ISLET ISOLATION 128
Mononuclear cell infiltration of intra-pancreatic fat and decreased islet beta cell area in human type 2 diabetes 128
Triticum vulgare Extract Modulates Protein-Kinase B and Matrix Metalloproteinases 9 Protein Expression in BV-2 Cells: Bioactivity on Inflammatory Pathway Associated with Molecular Mechanism Wound Healing 128
Intra-pancreatic fat mononuclear cell infiltration: A link between visceral fat accumulation and beta-cell failure in human type 2 diabetes? 127
Treatment strategy for pancreatic IPMNs: prognostic impact of conservative surgery 126
PANCREATIC CYSTIC LESIONS’ FOLLOW-UP WITH ABDOMINAL ULTRASOUND SCAN: COULD IT PLAY AN ALTERNATIVE ROLE TO THE ROUTINE USE OF MRI? 125
The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms. 124
Development of 3D models of pancreatic ductal adenocarcinoma via tissue engineering 124
MICROSATELLITE INSTABILITY AND TUMOR VOLUME INVERSELY AFFECT EARLY PROGRESSION FREE SURVIVAL IN ADJUVANT SETTING OF PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA: LIGHTS AND SHADOWS OF MOLECULAR PATHOLOGY AND IMMUNOTHERAPY 124
Dysregulated insulin secretion is associated with pancreatic β-cell hyperplasia and direct acinar-β-cell trans-differentiation in partially eNOS-deficient mice 123
NSC631570 affects MMP9, HENT1, and SPARC expression in cell cultures of pancreatic cancer. Can we use it in combination with gemcitabine/nab-paclitaxel? 123
COMPARISON BETWEEN ROBOTIC ASSISTED AND THE “GOLD STANDARD” OPEN APPROACH FOR LEFT SIDE CYSTIC TUMOR OF THE PANCREAS: RESULTS FROM A SINGLE CENTER 122
EARLY MONOCENTRIC EXPERIENCE IN EUS-FNA WET-TECHNIQUE FOR PANCREATIC LESIONS 120
APOPTOSIS IN A SERIES OF GEP-NET 116
3D In Vitro Model of Pancreatic Ductal Adenocarcinoma: New Strategy to Study Pancreatic Ductal Carcinoma 115
The occurrence of prion protein in surgically resected pancreatic adenocarcinoma 113
Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA study 113
Prognostic impact of conservative surgery for pancreatic IPMNs 113
Synergistic Interaction of Novel Lactate Dehydrogenase Inhibitors with Gemcitabine in Hypoxic Models of Pancreatic Cancer 112
Cheilognatopalatoschisi: Analisi morfologica ed istoenzimatica del muscolo orbicolare della bocca 110
DOES INTRAPANCREATIC FAT ACCUMULATION INFLUENCE ISLETS FUNCTION AND SURVIVAL IN TYPE 2 DIABETIC PATIENTS? A STUDY WITH ISOLATED PANCREATIC ISLETS 109
P53 STATUS AND RESPONSE TO GEMCITABINE BASED THERAPY IN PANCREATIC CARCINOMA PATIENTS 108
PANCREATIC CYSTIC LESIONS IN FOLLOW-UP: COULD ABDOMINAL ULTRASOUND SCAN REPRESENT A SAFE AND COST-SAVING ALTERNATIVE TO MRI? 108
Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms 107
Silver nanoparticle-coated polyhydroxyalkanoate based electrospun fibers for wound dressing applications 107
LASER MICRODISSECTION (LMD) AND PRIMARY CELL CULTURES IMPROVE PHARMACOGENETIC ANALYSIS IN PANCREATIC ADENOCARCINOMA ALLOWING THE USE OF GENE EXPRESSION LEVELS AND WHO GRADING AS PROGNOSTIC MARKERS 106
Unilateral Adrenal Hyperplasia in the Presence of a Reninoma in a Young Pregnant Woman 105
TRANSFECTION OF SIRNA FOR ERK1-2 IN PRIMARY PANCREATIC CANCER CELLS CULTURES BY ELECTROPORATION REDUCE THE CELL GROWTH IN VITRO 103
IDENTIFICATION OF PATHOLOGICAL AMPULLARY ADENOCARCINOMAS SUBTYPES AND THEIR PROGNOSIS USING THE IMMUNOHISTOCHEMICAL SCORE OF CDX2, CK7 AND CK 20 103
ROBOTIC ASSISTED VERSUS OPEN LEFT PANCREATECTOMY FOR CYSTIC TUMORS: A SINGLE CENTER EXPERIENCE 103
Tissue microarray-chip featuring computerized immunophenotypical characterization more accurately subtypes ampullary adenocarcinoma than routine histology 103
LOW-DOSE RADIOTHERAPY ENHANCES CELLULAR GROWTH IN A IN VITRO MODEL FOR PANCREATIC DUCTAL ADENOCARCINOMA 100
Totale 20.050
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.455
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.455
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021662 0 0 0 0 0 100 107 67 117 71 46 154
2021/20221.380 18 89 38 81 246 183 45 93 51 57 132 347
2022/20231.766 197 265 147 131 223 213 20 114 297 14 120 25
2023/20247.170 167 163 201 98 243 278 64 51 23 5.645 90 147
2024/20253.651 39 130 40 239 400 427 284 180 381 499 312 720
2025/20262.222 258 446 448 267 477 326 0 0 0 0 0 0
Totale 21.464